Clinical Trial Update: Abemaciclib Dose Escalation to Maintain Intensity (ADE-MI) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating escalating doses of abemaciclib to maintain treatment intensity in breast cancer; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• VERZENIO (ABEMACICLIB)

Snippet

Sponsor: University of Illinois at Chicago | Conditions: Breast Cancer | Phase 4 | Status: RECRUITING